Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Steemson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
British Medical Journal (Clinical Research Ed.)|October 1, 1983
Risk factors for severe retinopathy in non-insulin dependent diabetesT Dornan, C Peckar, J Steemson
Diabetes Research (Edinburgh, Scotland)|December 1, 1991
Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemiaR R Holman, J Steemson, R C Turner
Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1987
Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplementR R Holman, J Steemson, R C Turner
Diabetes Care|January 1, 1987
No glycemic benefit from guar administration in NIDDMR R Holman, J Steemson, P Darling, et al.
British Medical Journal (Clinical Research Ed.)|March 3, 1984
Human ultralente insulinR R Holman, J Steemson, P Darling, et al.
Diabetes Research (Edinburgh, Scotland)|December 1, 1990
Rapid restoration of normoglycaemia using intravenous insulin bolusesJ M Dunnett, J Steemson, J W Sear, et al.
Lancet (London, England)|April 4, 1987
Pen-sized digital 30-second blood glucose meterD R Matthews, R R Holman, E Bown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 1991
Capillary and venous blood glucose measurements using a direct glucose-sensing meterD R Matthews, S F Burton, E Bown, et al.
Lancet (London, England)|January 29, 1983
Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective studyR R Holman, T L Dornan, V Mayon-White, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
British Medical Journal (Clinical Research Ed.)|October 1, 1983
Risk factors for severe retinopathy in non-insulin dependent diabetesT Dornan, C Peckar, J Steemson
Diabetes Research (Edinburgh, Scotland)|December 1, 1991
Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemiaR R Holman, J Steemson, R C Turner
Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1987
Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplementR R Holman, J Steemson, R C Turner
Diabetes Care|January 1, 1987
No glycemic benefit from guar administration in NIDDMR R Holman, J Steemson, P Darling, et al.
British Medical Journal (Clinical Research Ed.)|March 3, 1984
Human ultralente insulinR R Holman, J Steemson, P Darling, et al.
Diabetes Research (Edinburgh, Scotland)|December 1, 1990
Rapid restoration of normoglycaemia using intravenous insulin bolusesJ M Dunnett, J Steemson, J W Sear, et al.
Lancet (London, England)|April 4, 1987
Pen-sized digital 30-second blood glucose meterD R Matthews, R R Holman, E Bown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 1991
Capillary and venous blood glucose measurements using a direct glucose-sensing meterD R Matthews, S F Burton, E Bown, et al.
Lancet (London, England)|January 29, 1983
Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective studyR R Holman, T L Dornan, V Mayon-White, et al.
Pageof 1